Fachliteratur Gastroenterologie: Leberzirrhose

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Leberzirrhose

14. Januar 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1888


	Artikel 1 - 20 / 37742

	Hemodynamic impact of dexmedetomidine in critically ill patients with and without cirrhosis: A retrospective cohort study. J Crit Care Conroy GM, Yerke JR, Rudoni MA, Kapoor A, Bass SN. PMID: 41529525 [PubMed - as supplied by publisher]
	Zinc supplementation in liver cirrhosis: meta-analysis of its effect on biochemical and clinical outcomes. BMC Nutr Gong Y, Yang Z, Sun G, Xue X, Zhang X. PMID: 41527112 [PubMed - as supplied by publisher]
	First-phase ejection fraction for evaluating early left ventricular systolic function in patients with cirrhosis. J Int Med Res Yang X, Wang X, Jiang G, Nie J, Yang J, Li G, Yang B. PMID: 41521148 [PubMed - indexed for MEDLINE]
	Prevention and treatment of thrombosis in patients with decompensated cirrhosis. J Thromb Haemost Bell C, Afzal A, Carlin S, Roberts LN. PMID: 41520803 [PubMed - as supplied by publisher]
	Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta-Analysis. Aliment Pharmacol Ther Moraes BF, Leite GAPD, Silveira IB, Leite GAPD, Fonseca MLM, Suffert LC, Visentini LM, Beis LPP, Cançado GGL. PMID: 41518144 [PubMed - as supplied by publisher]
	Increased Intrahepatic Mast Cell Density in Liver Cirrhosis Due to MASLD and Other Non-Infectious Chronic Liver Diseases. Int J Mol Sci Ortiz-López N, Pinto-León A, Favi J, Guíñez Francois D, Aleman L, Carreño-Toro L, Zazueta A, Magne F, Poniachik J, Beltrán CJ. PMID: 41516266 [PubMed - indexed for MEDLINE]
	Association of NT-proBNP and sST2 with Diastolic Dysfunction in Cirrhotic Patients and Its Therapeutic Implications. Int J Mol Sci Chiorescu RM, Ruda A, Chira R, Nagy G, Bin, Chiorescu , Mocan M. PMID: 41516138 [PubMed - indexed for MEDLINE]
	Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to Therapy. Int J Mol Sci Mansour GK, Hajjar AW, Marafini I, Monteleone G. PMID: 41516036 [PubMed - indexed for MEDLINE]
	Plasma Adsorption Perfusion (BR-350) Versus Open Albumin Dialysis (OPAL) for Hyperbilirubinemia in Hepatic Failure in Cirrhotic Patients. Artif Organs Friebus-Kardash J, Ochs A, Louzi A, Kribben A, Tyczynski B, Rashidi-Alavijeh J, Schütte A, Schmidt HH, Zeller A. PMID: 41514160 [PubMed - as supplied by publisher]
	National trend and impact of compensated cirrhosis in patients who underwent metabolic and bariatric surgery: a Nationwide Readmissions Database study. Surg Endosc Esparham A, Phillippe S, Khorgami Z. PMID: 41514130 [PubMed - as supplied by publisher]
	Evaluating the clinical care, quality of life and overall experiences of patients with primary biliary cholangitis (PBC) during the pandemic: A Canadian mixed-methods study. PLoS One Baguley E, Knaub M, VanDyke J, Hirschfield G, Swain MG, Wright G, McCaughey D, Shaheen AA. PMID: 41511983 [PubMed - indexed for MEDLINE]
	Retrospective Analysis of Diagnostic and Prognostic Value of Serum Glypican-3 in Patients With HCV-Related Cirrhosis With Or Without HCC After Achieving SVR With DAA Treatment. J Gastrointest Cancer Caviglia GP, Guariglia M, Gaia S, Troshina Y, Rolle E, Saba F, Dileo E, Carucci P, Ciancio A. PMID: 41511652 [PubMed - indexed for MEDLINE]
	NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR DISEASE: ASSOCIATIONS WITH CLINICAL MARKERS AND METABOLIC ALTERATIONS. Georgian Med News Agzamkhodjaeva S, Nuritdinov N, Hamraev A, Muhamedova M, Khalimova F. PMID: 41511118 [PubMed - indexed for MEDLINE]
	Agile 3+ Index Is Independently Associated With Cardiovascular Diseases in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: Analysis of NHANES 2017-2020. Diabetes Metab Res Rev Li Y, Yang M, Yue J, Wang Z, Qi Y, Liu Q, Ma J. PMID: 41508788 [PubMed - indexed for MEDLINE]
	Associations Between Mean Arterial Pressure Thresholds and Clinical Outcomes in Decompensated Cirrhosis With Septic Shock. Am J Gastroenterol Patidar KR, Hall L, Ogola GO, Pike F, Maiwall R, Karvellas CJ, Syed F, Garrido-Trevino LF, Walker OC, Shankar N, Cullaro G, Mogri M, Iyer N, Asrani SK. PMID: 41504279 [PubMed - as supplied by publisher]
	Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study. Hepatol Res Takakusagi S, Kakizaki S, Yokoyama Y, Kizawa K, Marubashi K, Kosone T, Hatanaka T, Naganuma A, Tojima H, Yamazaki Y, Uraoka T, Takagi H. PMID: 41503821 [PubMed - as supplied by publisher]
	The Role of Changes in the Proportion of Fecal Short-Chain Fatty Acids on the Severity of Hepatic Encephalopathy in Cirrhosis Patients. Acta Med Indones Ferdianto MA, Kurniawan J, Maulahela H, Rumende CM, Subekti I, Rinaldi I, Shatri H, Lesmana CR. PMID: 41502202 [PubMed - indexed for MEDLINE]
	Short-Chain Fatty Acids in the Gut-Brain-Liver Axis: Implications for Hepatic Encephalopathy. Acta Med Indones Hasan I. PMID: 41502197 [PubMed - indexed for MEDLINE]
	Using Physiologically Based Pharmacokinetic Modeling and Simulations to Predict Antihypertensive Drug Doses in Cirrhotic Patients. J Clin Pharmacol Tarek M, Ali AA, Biomy R, Abdelkawy K, El-Khateeb E. PMID: 41499374 [PubMed - indexed for MEDLINE]
	Identifying subjects at risk of liver cirrhosis via a range of thresholds for common fibrosis markers: A Welsh general population-based cohort study. J Intern Med Hill TA, West J, Morling JR, Crooks CJ. PMID: 41496649 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 37742

Seite 1 von 1888



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung